Tsumura & Co.
Tsumura & Co. (TSMRF) Stock Competitors & Peer Comparison
See (TSMRF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TSMRF | $23.74 | +0.01% | 1.8B | 8.19 | $2.90 | +3.92% |
| MKGAF | $134.65 | -1.72% | 58.5B | 17.69 | $7.61 | +1.86% |
| MKKGY | $26.67 | -0.52% | 55.1B | 17.49 | $1.52 | +1.88% |
| HLNCF | $4.90 | -0.51% | 44B | 23.33 | $0.21 | +1.78% |
| IPSEY | $32.42 | -1.76% | 42.9B | 26.15 | $1.24 | +0.80% |
| TKPHF | $27.05 | -8.31% | 42.6B | 60.11 | $0.45 | +4.92% |
| SDZNY | $59.42 | -1.35% | 25.6B | -2970.00 | -$0.02 | +1.14% |
| ESALY | $61.51 | -2.11% | 17.6B | 20.54 | $3.00 | N/A |
| TEVJF | $14.00 | +0.00% | 16.1B | -12.17 | -$1.15 | N/A |
| SGIOY | $8.61 | +0.41% | 14.6B | 12.66 | $0.68 | +1.85% |
Stock Comparison
TSMRF vs MKGAF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, MKGAF has a market cap of 58.5B. Regarding current trading prices, TSMRF is priced at $23.74, while MKGAF trades at $134.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas MKGAF's P/E ratio is 17.69. In terms of profitability, TSMRF's ROE is +0.11%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, TSMRF and MKGAF have similar daily volatility (0.00).Check MKGAF's competition here
TSMRF vs MKKGY Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, MKKGY has a market cap of 55.1B. Regarding current trading prices, TSMRF is priced at $23.74, while MKKGY trades at $26.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas MKKGY's P/E ratio is 17.49. In terms of profitability, TSMRF's ROE is +0.11%, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, TSMRF is less volatile compared to MKKGY. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check MKKGY's competition here
TSMRF vs HLNCF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, HLNCF has a market cap of 44B. Regarding current trading prices, TSMRF is priced at $23.74, while HLNCF trades at $4.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas HLNCF's P/E ratio is 23.33. In terms of profitability, TSMRF's ROE is +0.11%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, TSMRF is less volatile compared to HLNCF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check HLNCF's competition here
TSMRF vs IPSEY Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, IPSEY has a market cap of 42.9B. Regarding current trading prices, TSMRF is priced at $23.74, while IPSEY trades at $32.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas IPSEY's P/E ratio is 26.15. In terms of profitability, TSMRF's ROE is +0.11%, compared to IPSEY's ROE of +0.17%. Regarding short-term risk, TSMRF is less volatile compared to IPSEY. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check IPSEY's competition here
TSMRF vs TKPHF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, TKPHF has a market cap of 42.6B. Regarding current trading prices, TSMRF is priced at $23.74, while TKPHF trades at $27.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas TKPHF's P/E ratio is 60.11. In terms of profitability, TSMRF's ROE is +0.11%, compared to TKPHF's ROE of +0.01%. Regarding short-term risk, TSMRF and TKPHF have similar daily volatility (0.00).Check TKPHF's competition here
TSMRF vs SDZNY Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, SDZNY has a market cap of 25.6B. Regarding current trading prices, TSMRF is priced at $23.74, while SDZNY trades at $59.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas SDZNY's P/E ratio is -2970.00. In terms of profitability, TSMRF's ROE is +0.11%, compared to SDZNY's ROE of +0.00%. Regarding short-term risk, TSMRF is less volatile compared to SDZNY. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check SDZNY's competition here
TSMRF vs ESALY Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, TSMRF is priced at $23.74, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas ESALY's P/E ratio is 20.54. In terms of profitability, TSMRF's ROE is +0.11%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, TSMRF is less volatile compared to ESALY. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check ESALY's competition here
TSMRF vs TEVJF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, TEVJF has a market cap of 16.1B. Regarding current trading prices, TSMRF is priced at $23.74, while TEVJF trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas TEVJF's P/E ratio is -12.17. In terms of profitability, TSMRF's ROE is +0.11%, compared to TEVJF's ROE of -0.21%. Regarding short-term risk, TSMRF is less volatile compared to TEVJF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check TEVJF's competition here
TSMRF vs SGIOY Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, SGIOY has a market cap of 14.6B. Regarding current trading prices, TSMRF is priced at $23.74, while SGIOY trades at $8.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas SGIOY's P/E ratio is 12.66. In terms of profitability, TSMRF's ROE is +0.11%, compared to SGIOY's ROE of +0.05%. Regarding short-term risk, TSMRF is less volatile compared to SGIOY. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check SGIOY's competition here
TSMRF vs SGIOF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, SGIOF has a market cap of 14.3B. Regarding current trading prices, TSMRF is priced at $23.74, while SGIOF trades at $16.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas SGIOF's P/E ratio is 12.36. In terms of profitability, TSMRF's ROE is +0.11%, compared to SGIOF's ROE of +0.05%. Regarding short-term risk, TSMRF is less volatile compared to SGIOF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check SGIOF's competition here
TSMRF vs BIOVF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, BIOVF has a market cap of 10.3B. Regarding current trading prices, TSMRF is priced at $23.74, while BIOVF trades at $29.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas BIOVF's P/E ratio is 22.40. In terms of profitability, TSMRF's ROE is +0.11%, compared to BIOVF's ROE of +0.10%. Regarding short-term risk, TSMRF and BIOVF have similar daily volatility (0.00).Check BIOVF's competition here
TSMRF vs IPSEF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, IPSEF has a market cap of 9.4B. Regarding current trading prices, TSMRF is priced at $23.74, while IPSEF trades at $113.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas IPSEF's P/E ratio is 22.58. In terms of profitability, TSMRF's ROE is +0.11%, compared to IPSEF's ROE of +0.14%. Regarding short-term risk, TSMRF is less volatile compared to IPSEF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check IPSEF's competition here
TSMRF vs ESAIY Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, ESAIY has a market cap of 8B. Regarding current trading prices, TSMRF is priced at $23.74, while ESAIY trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas ESAIY's P/E ratio is 25.07. In terms of profitability, TSMRF's ROE is +0.11%, compared to ESAIY's ROE of +0.03%. Regarding short-term risk, TSMRF is less volatile compared to ESAIY. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check ESAIY's competition here
TSMRF vs SFOSF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, SFOSF has a market cap of 7.6B. Regarding current trading prices, TSMRF is priced at $23.74, while SFOSF trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas SFOSF's P/E ratio is 13.03. In terms of profitability, TSMRF's ROE is +0.11%, compared to SFOSF's ROE of +0.06%. Regarding short-term risk, TSMRF and SFOSF have similar daily volatility (0.00).Check SFOSF's competition here
TSMRF vs ESALF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, ESALF has a market cap of 7.2B. Regarding current trading prices, TSMRF is priced at $23.74, while ESALF trades at $25.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas ESALF's P/E ratio is 22.85. In terms of profitability, TSMRF's ROE is +0.11%, compared to ESALF's ROE of +0.03%. Regarding short-term risk, TSMRF and ESALF have similar daily volatility (0.00).Check ESALF's competition here
TSMRF vs HKMPF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, HKMPF has a market cap of 6.2B. Regarding current trading prices, TSMRF is priced at $23.74, while HKMPF trades at $27.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas HKMPF's P/E ratio is 17.37. In terms of profitability, TSMRF's ROE is +0.11%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, TSMRF and HKMPF have similar daily volatility (0.00).Check HKMPF's competition here
TSMRF vs HKMPY Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, HKMPY has a market cap of 6.1B. Regarding current trading prices, TSMRF is priced at $23.74, while HKMPY trades at $55.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas HKMPY's P/E ratio is 17.08. In terms of profitability, TSMRF's ROE is +0.11%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, TSMRF is less volatile compared to HKMPY. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check HKMPY's competition here
TSMRF vs GZPHF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, GZPHF has a market cap of 5.8B. Regarding current trading prices, TSMRF is priced at $23.74, while GZPHF trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas GZPHF's P/E ratio is 10.26. In terms of profitability, TSMRF's ROE is +0.11%, compared to GZPHF's ROE of +0.07%. Regarding short-term risk, TSMRF and GZPHF have similar daily volatility (0.00).Check GZPHF's competition here
TSMRF vs SGFEF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, SGFEF has a market cap of 5.2B. Regarding current trading prices, TSMRF is priced at $23.74, while SGFEF trades at $114.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas SGFEF's P/E ratio is 24.64. In terms of profitability, TSMRF's ROE is +0.11%, compared to SGFEF's ROE of +0.11%. Regarding short-term risk, TSMRF is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check SGFEF's competition here
TSMRF vs WIBFF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, WIBFF has a market cap of 5B. Regarding current trading prices, TSMRF is priced at $23.74, while WIBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas WIBFF's P/E ratio is -0.01. In terms of profitability, TSMRF's ROE is +0.11%, compared to WIBFF's ROE of +0.00%. Regarding short-term risk, TSMRF is less volatile compared to WIBFF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check WIBFF's competition here
TSMRF vs HLBBF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, HLBBF has a market cap of 4.1B. Regarding current trading prices, TSMRF is priced at $23.74, while HLBBF trades at $5.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas HLBBF's P/E ratio is 9.90. In terms of profitability, TSMRF's ROE is +0.11%, compared to HLBBF's ROE of +0.14%. Regarding short-term risk, TSMRF and HLBBF have similar daily volatility (0.00).Check HLBBF's competition here
TSMRF vs CHSYF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, CHSYF has a market cap of 3.7B. Regarding current trading prices, TSMRF is priced at $23.74, while CHSYF trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas CHSYF's P/E ratio is 16.85. In terms of profitability, TSMRF's ROE is +0.11%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, TSMRF and CHSYF have similar daily volatility (0.00).Check CHSYF's competition here
TSMRF vs LVZPF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, LVZPF has a market cap of 3.5B. Regarding current trading prices, TSMRF is priced at $23.74, while LVZPF trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas LVZPF's P/E ratio is 11.43. In terms of profitability, TSMRF's ROE is +0.11%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, TSMRF is less volatile compared to LVZPF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check LVZPF's competition here
TSMRF vs ULIHF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, ULIHF has a market cap of 3.4B. Regarding current trading prices, TSMRF is priced at $23.74, while ULIHF trades at $1.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas ULIHF's P/E ratio is 9.25. In terms of profitability, TSMRF's ROE is +0.11%, compared to ULIHF's ROE of +0.21%. Regarding short-term risk, TSMRF and ULIHF have similar daily volatility (0.00).Check ULIHF's competition here
TSMRF vs HLUBF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, HLUBF has a market cap of 3.4B. Regarding current trading prices, TSMRF is priced at $23.74, while HLUBF trades at $3.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas HLUBF's P/E ratio is 7.12. In terms of profitability, TSMRF's ROE is +0.11%, compared to HLUBF's ROE of +0.14%. Regarding short-term risk, TSMRF and HLUBF have similar daily volatility (0.00).Check HLUBF's competition here
TSMRF vs APNHF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, APNHF has a market cap of 3.2B. Regarding current trading prices, TSMRF is priced at $23.74, while APNHF trades at $7.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas APNHF's P/E ratio is 12.72. In terms of profitability, TSMRF's ROE is +0.11%, compared to APNHF's ROE of +0.04%. Regarding short-term risk, TSMRF is less volatile compared to APNHF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check APNHF's competition here
TSMRF vs SMDPY Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, SMDPY has a market cap of 3.1B. Regarding current trading prices, TSMRF is priced at $23.74, while SMDPY trades at $7.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas SMDPY's P/E ratio is 19.42. In terms of profitability, TSMRF's ROE is +0.11%, compared to SMDPY's ROE of +0.15%. Regarding short-term risk, TSMRF and SMDPY have similar daily volatility (0.00).Check SMDPY's competition here
TSMRF vs INVVY Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, TSMRF is priced at $23.74, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas INVVY's P/E ratio is -62.42. In terms of profitability, TSMRF's ROE is +0.11%, compared to INVVY's ROE of -0.01%. Regarding short-term risk, TSMRF and INVVY have similar daily volatility (0.00).Check INVVY's competition here
TSMRF vs APNHY Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, APNHY has a market cap of 3B. Regarding current trading prices, TSMRF is priced at $23.74, while APNHY trades at $6.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas APNHY's P/E ratio is 11.90. In terms of profitability, TSMRF's ROE is +0.11%, compared to APNHY's ROE of +0.05%. Regarding short-term risk, TSMRF is less volatile compared to APNHY. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check APNHY's competition here
TSMRF vs HYPMY Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, HYPMY has a market cap of 2.9B. Regarding current trading prices, TSMRF is priced at $23.74, while HYPMY trades at $4.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas HYPMY's P/E ratio is 20.22. In terms of profitability, TSMRF's ROE is +0.11%, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, TSMRF is less volatile compared to HYPMY. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check HYPMY's competition here
TSMRF vs IZQVF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, TSMRF is priced at $23.74, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, TSMRF's ROE is +0.11%, compared to IZQVF's ROE of -0.01%. Regarding short-term risk, TSMRF and IZQVF have similar daily volatility (0.00).Check IZQVF's competition here
TSMRF vs DNPUF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, DNPUF has a market cap of 2.9B. Regarding current trading prices, TSMRF is priced at $23.74, while DNPUF trades at $7.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas DNPUF's P/E ratio is 18.10. In terms of profitability, TSMRF's ROE is +0.11%, compared to DNPUF's ROE of +0.15%. Regarding short-term risk, TSMRF is less volatile compared to DNPUF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check DNPUF's competition here
TSMRF vs LBTSF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, LBTSF has a market cap of 2.9B. Regarding current trading prices, TSMRF is priced at $23.74, while LBTSF trades at $13.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas LBTSF's P/E ratio is 102.77. In terms of profitability, TSMRF's ROE is +0.11%, compared to LBTSF's ROE of +0.02%. Regarding short-term risk, TSMRF and LBTSF have similar daily volatility (0.00).Check LBTSF's competition here
TSMRF vs HMDCF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, HMDCF has a market cap of 2.8B. Regarding current trading prices, TSMRF is priced at $23.74, while HMDCF trades at $3.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas HMDCF's P/E ratio is -64.10. In terms of profitability, TSMRF's ROE is +0.11%, compared to HMDCF's ROE of -0.01%. Regarding short-term risk, TSMRF and HMDCF have similar daily volatility (0.00).Check HMDCF's competition here
TSMRF vs THCBF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, THCBF has a market cap of 2.4B. Regarding current trading prices, TSMRF is priced at $23.74, while THCBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas THCBF's P/E ratio is -0.10. In terms of profitability, TSMRF's ROE is +0.11%, compared to THCBF's ROE of +0.00%. Regarding short-term risk, TSMRF is less volatile compared to THCBF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check THCBF's competition here
TSMRF vs DMPHF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, TSMRF is priced at $23.74, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas DMPHF's P/E ratio is 17.90. In terms of profitability, TSMRF's ROE is +0.11%, compared to DMPHF's ROE of +0.17%. Regarding short-term risk, TSMRF is less volatile compared to DMPHF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check DMPHF's competition here
TSMRF vs HTSUF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, HTSUF has a market cap of 2.1B. Regarding current trading prices, TSMRF is priced at $23.74, while HTSUF trades at $28.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas HTSUF's P/E ratio is 15.99. In terms of profitability, TSMRF's ROE is +0.11%, compared to HTSUF's ROE of +0.08%. Regarding short-term risk, TSMRF is less volatile compared to HTSUF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check HTSUF's competition here
TSMRF vs LJUIF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, LJUIF has a market cap of 2.1B. Regarding current trading prices, TSMRF is priced at $23.74, while LJUIF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas LJUIF's P/E ratio is 13.97. In terms of profitability, TSMRF's ROE is +0.11%, compared to LJUIF's ROE of +0.19%. Regarding short-term risk, TSMRF and LJUIF have similar daily volatility (0.00).Check LJUIF's competition here
TSMRF vs ARSUF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, ARSUF has a market cap of 1.8B. Regarding current trading prices, TSMRF is priced at $23.74, while ARSUF trades at $25.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas ARSUF's P/E ratio is 22.70. In terms of profitability, TSMRF's ROE is +0.11%, compared to ARSUF's ROE of +0.16%. Regarding short-term risk, TSMRF and ARSUF have similar daily volatility (0.00).Check ARSUF's competition here
TSMRF vs NPNKF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, NPNKF has a market cap of 1.7B. Regarding current trading prices, TSMRF is priced at $23.74, while NPNKF trades at $25.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas NPNKF's P/E ratio is 7.80. In terms of profitability, TSMRF's ROE is +0.11%, compared to NPNKF's ROE of +0.14%. Regarding short-term risk, TSMRF is less volatile compared to NPNKF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check NPNKF's competition here
TSMRF vs MITPF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, TSMRF is priced at $23.74, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas MITPF's P/E ratio is -10.81. In terms of profitability, TSMRF's ROE is +0.11%, compared to MITPF's ROE of +4.92%. Regarding short-term risk, TSMRF is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check MITPF's competition here
TSMRF vs KARBF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, TSMRF is priced at $23.74, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas KARBF's P/E ratio is 262.50. In terms of profitability, TSMRF's ROE is +0.11%, compared to KARBF's ROE of N/A. Regarding short-term risk, TSMRF and KARBF have similar daily volatility (0.00).Check KARBF's competition here
TSMRF vs EVOTF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, EVOTF has a market cap of 1.5B. Regarding current trading prices, TSMRF is priced at $23.74, while EVOTF trades at $8.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas EVOTF's P/E ratio is -6.17. In terms of profitability, TSMRF's ROE is +0.11%, compared to EVOTF's ROE of -0.22%. Regarding short-term risk, TSMRF is less volatile compared to EVOTF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check EVOTF's competition here
TSMRF vs CASBF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, CASBF has a market cap of 1.5B. Regarding current trading prices, TSMRF is priced at $23.74, while CASBF trades at $4.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas CASBF's P/E ratio is -23.33. In terms of profitability, TSMRF's ROE is +0.11%, compared to CASBF's ROE of -0.14%. Regarding short-term risk, TSMRF is less volatile compared to CASBF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check CASBF's competition here
TSMRF vs GTBIF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, GTBIF has a market cap of 1.5B. Regarding current trading prices, TSMRF is priced at $23.74, while GTBIF trades at $6.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas GTBIF's P/E ratio is 29.29. In terms of profitability, TSMRF's ROE is +0.11%, compared to GTBIF's ROE of +0.03%. Regarding short-term risk, TSMRF is less volatile compared to GTBIF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check GTBIF's competition here
TSMRF vs SHEZF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, SHEZF has a market cap of 1.4B. Regarding current trading prices, TSMRF is priced at $23.74, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, TSMRF's ROE is +0.11%, compared to SHEZF's ROE of +0.05%. Regarding short-term risk, TSMRF and SHEZF have similar daily volatility (0.00).Check SHEZF's competition here
TSMRF vs NPPNY Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, NPPNY has a market cap of 1.4B. Regarding current trading prices, TSMRF is priced at $23.74, while NPPNY trades at $5.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas NPPNY's P/E ratio is 6.59. In terms of profitability, TSMRF's ROE is +0.11%, compared to NPPNY's ROE of +0.09%. Regarding short-term risk, TSMRF and NPPNY have similar daily volatility (0.00).Check NPPNY's competition here
TSMRF vs CHIZF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, CHIZF has a market cap of 1.4B. Regarding current trading prices, TSMRF is priced at $23.74, while CHIZF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas CHIZF's P/E ratio is 13.75. In terms of profitability, TSMRF's ROE is +0.11%, compared to CHIZF's ROE of +0.04%. Regarding short-term risk, TSMRF and CHIZF have similar daily volatility (0.00).Check CHIZF's competition here
TSMRF vs SWGHF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, SWGHF has a market cap of 1.1B. Regarding current trading prices, TSMRF is priced at $23.74, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, TSMRF's ROE is +0.11%, compared to SWGHF's ROE of +0.12%. Regarding short-term risk, TSMRF and SWGHF have similar daily volatility (0.00).Check SWGHF's competition here
TSMRF vs KSPHF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, KSPHF has a market cap of 1.1B. Regarding current trading prices, TSMRF is priced at $23.74, while KSPHF trades at $27.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas KSPHF's P/E ratio is 14.51. In terms of profitability, TSMRF's ROE is +0.11%, compared to KSPHF's ROE of +0.06%. Regarding short-term risk, TSMRF and KSPHF have similar daily volatility (0.00).Check KSPHF's competition here
TSMRF vs CURLF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, CURLF has a market cap of 1.1B. Regarding current trading prices, TSMRF is priced at $23.74, while CURLF trades at $1.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas CURLF's P/E ratio is -4.38. In terms of profitability, TSMRF's ROE is +0.11%, compared to CURLF's ROE of -0.25%. Regarding short-term risk, TSMRF is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check CURLF's competition here
TSMRF vs GNMLF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, GNMLF has a market cap of 1.1B. Regarding current trading prices, TSMRF is priced at $23.74, while GNMLF trades at $1.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas GNMLF's P/E ratio is 10.90. In terms of profitability, TSMRF's ROE is +0.11%, compared to GNMLF's ROE of +0.12%. Regarding short-term risk, TSMRF and GNMLF have similar daily volatility (0.00).Check GNMLF's competition here
TSMRF vs KKPCF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, KKPCF has a market cap of 1B. Regarding current trading prices, TSMRF is priced at $23.74, while KKPCF trades at $28.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas KKPCF's P/E ratio is 11.33. In terms of profitability, TSMRF's ROE is +0.11%, compared to KKPCF's ROE of +0.09%. Regarding short-term risk, TSMRF is less volatile compared to KKPCF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check KKPCF's competition here
TSMRF vs BIOGY Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, BIOGY has a market cap of 960.3M. Regarding current trading prices, TSMRF is priced at $23.74, while BIOGY trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas BIOGY's P/E ratio is 32.50. In terms of profitability, TSMRF's ROE is +0.11%, compared to BIOGY's ROE of +0.18%. Regarding short-term risk, TSMRF and BIOGY have similar daily volatility (0.00).Check BIOGY's competition here
TSMRF vs SHPHF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, SHPHF has a market cap of 924.4M. Regarding current trading prices, TSMRF is priced at $23.74, while SHPHF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas SHPHF's P/E ratio is -3.33. In terms of profitability, TSMRF's ROE is +0.11%, compared to SHPHF's ROE of -0.01%. Regarding short-term risk, TSMRF is less volatile compared to SHPHF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check SHPHF's competition here
TSMRF vs TCNNF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, TCNNF has a market cap of 915.3M. Regarding current trading prices, TSMRF is priced at $23.74, while TCNNF trades at $4.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas TCNNF's P/E ratio is -6.06. In terms of profitability, TSMRF's ROE is +0.11%, compared to TCNNF's ROE of -0.13%. Regarding short-term risk, TSMRF is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check TCNNF's competition here
TSMRF vs LVTTF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, LVTTF has a market cap of 901.7M. Regarding current trading prices, TSMRF is priced at $23.74, while LVTTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas LVTTF's P/E ratio is -0.02. In terms of profitability, TSMRF's ROE is +0.11%, compared to LVTTF's ROE of +0.00%. Regarding short-term risk, TSMRF is less volatile compared to LVTTF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check LVTTF's competition here
TSMRF vs EVRRF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, EVRRF has a market cap of 897.8M. Regarding current trading prices, TSMRF is priced at $23.74, while EVRRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas EVRRF's P/E ratio is -0.08. In terms of profitability, TSMRF's ROE is +0.11%, compared to EVRRF's ROE of +2.97%. Regarding short-term risk, TSMRF and EVRRF have similar daily volatility (0.00).Check EVRRF's competition here
TSMRF vs NRXCF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, NRXCF has a market cap of 851.9M. Regarding current trading prices, TSMRF is priced at $23.74, while NRXCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas NRXCF's P/E ratio is -0.22. In terms of profitability, TSMRF's ROE is +0.11%, compared to NRXCF's ROE of +2.32%. Regarding short-term risk, TSMRF and NRXCF have similar daily volatility (0.00).Check NRXCF's competition here
TSMRF vs TWAPF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, TWAPF has a market cap of 828.5M. Regarding current trading prices, TSMRF is priced at $23.74, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas TWAPF's P/E ratio is 6.28. In terms of profitability, TSMRF's ROE is +0.11%, compared to TWAPF's ROE of +0.11%. Regarding short-term risk, TSMRF and TWAPF have similar daily volatility (0.00).Check TWAPF's competition here
TSMRF vs SWDCF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, SWDCF has a market cap of 773.6M. Regarding current trading prices, TSMRF is priced at $23.74, while SWDCF trades at $4.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas SWDCF's P/E ratio is 121.00. In terms of profitability, TSMRF's ROE is +0.11%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, TSMRF is less volatile compared to SWDCF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check SWDCF's competition here
TSMRF vs CSWYF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, CSWYF has a market cap of 758.4M. Regarding current trading prices, TSMRF is priced at $23.74, while CSWYF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas CSWYF's P/E ratio is 4.78. In terms of profitability, TSMRF's ROE is +0.11%, compared to CSWYF's ROE of +0.07%. Regarding short-term risk, TSMRF is less volatile compared to CSWYF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check CSWYF's competition here
TSMRF vs NIKA Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, NIKA has a market cap of 708.2M. Regarding current trading prices, TSMRF is priced at $23.74, while NIKA trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas NIKA's P/E ratio is N/A. In terms of profitability, TSMRF's ROE is +0.11%, compared to NIKA's ROE of +0.39%. Regarding short-term risk, TSMRF and NIKA have similar daily volatility (0.00).Check NIKA's competition here
TSMRF vs TRXPF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, TSMRF is priced at $23.74, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, TSMRF's ROE is +0.11%, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, TSMRF and TRXPF have similar daily volatility (0.00).Check TRXPF's competition here
TSMRF vs YIHCF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, YIHCF has a market cap of 643.1M. Regarding current trading prices, TSMRF is priced at $23.74, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, TSMRF's ROE is +0.11%, compared to YIHCF's ROE of +0.19%. Regarding short-term risk, TSMRF and YIHCF have similar daily volatility (0.00).Check YIHCF's competition here
TSMRF vs TRSSF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, TSMRF is priced at $23.74, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, TSMRF's ROE is +0.11%, compared to TRSSF's ROE of -0.32%. Regarding short-term risk, TSMRF is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check TRSSF's competition here
TSMRF vs ELTP Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, ELTP has a market cap of 578.2M. Regarding current trading prices, TSMRF is priced at $23.74, while ELTP trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas ELTP's P/E ratio is -26.99. In terms of profitability, TSMRF's ROE is +0.11%, compared to ELTP's ROE of -0.09%. Regarding short-term risk, TSMRF is less volatile compared to ELTP. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check ELTP's competition here
TSMRF vs AIHLF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, AIHLF has a market cap of 566M. Regarding current trading prices, TSMRF is priced at $23.74, while AIHLF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas AIHLF's P/E ratio is 12.07. In terms of profitability, TSMRF's ROE is +0.11%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, TSMRF and AIHLF have similar daily volatility (0.00).Check AIHLF's competition here
TSMRF vs PKBFF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, PKBFF has a market cap of 549.2M. Regarding current trading prices, TSMRF is priced at $23.74, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas PKBFF's P/E ratio is N/A. In terms of profitability, TSMRF's ROE is +0.11%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, TSMRF and PKBFF have similar daily volatility (0.00).Check PKBFF's competition here
TSMRF vs CCHWF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, TSMRF is priced at $23.74, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, TSMRF's ROE is +0.11%, compared to CCHWF's ROE of -7.05%. Regarding short-term risk, TSMRF is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check CCHWF's competition here
TSMRF vs BOIRF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, BOIRF has a market cap of 494.8M. Regarding current trading prices, TSMRF is priced at $23.74, while BOIRF trades at $28.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas BOIRF's P/E ratio is 20.07. In terms of profitability, TSMRF's ROE is +0.11%, compared to BOIRF's ROE of +0.06%. Regarding short-term risk, TSMRF and BOIRF have similar daily volatility (0.00).Check BOIRF's competition here
TSMRF vs PEXXF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, TSMRF is priced at $23.74, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, TSMRF's ROE is +0.11%, compared to PEXXF's ROE of N/A. Regarding short-term risk, TSMRF and PEXXF have similar daily volatility (0.00).Check PEXXF's competition here
TSMRF vs KHTRF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, KHTRF has a market cap of 448.8M. Regarding current trading prices, TSMRF is priced at $23.74, while KHTRF trades at $4.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas KHTRF's P/E ratio is 64.34. In terms of profitability, TSMRF's ROE is +0.11%, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, TSMRF and KHTRF have similar daily volatility (0.00).Check KHTRF's competition here
TSMRF vs AGYTF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, AGYTF has a market cap of 405.1M. Regarding current trading prices, TSMRF is priced at $23.74, while AGYTF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas AGYTF's P/E ratio is -8.50. In terms of profitability, TSMRF's ROE is +0.11%, compared to AGYTF's ROE of -2.67%. Regarding short-term risk, TSMRF is less volatile compared to AGYTF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check AGYTF's competition here
TSMRF vs HUMDF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, HUMDF has a market cap of 404M. Regarding current trading prices, TSMRF is priced at $23.74, while HUMDF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas HUMDF's P/E ratio is -13.69. In terms of profitability, TSMRF's ROE is +0.11%, compared to HUMDF's ROE of +8.06%. Regarding short-term risk, TSMRF and HUMDF have similar daily volatility (0.00).Check HUMDF's competition here
TSMRF vs GLASF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, GLASF has a market cap of 275.1M. Regarding current trading prices, TSMRF is priced at $23.74, while GLASF trades at $5.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas GLASF's P/E ratio is -61.11. In terms of profitability, TSMRF's ROE is +0.11%, compared to GLASF's ROE of +0.07%. Regarding short-term risk, TSMRF is less volatile compared to GLASF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check GLASF's competition here
TSMRF vs BHCCF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, BHCCF has a market cap of 271.6M. Regarding current trading prices, TSMRF is priced at $23.74, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, TSMRF's ROE is +0.11%, compared to BHCCF's ROE of +0.19%. Regarding short-term risk, TSMRF is less volatile compared to BHCCF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check BHCCF's competition here
TSMRF vs CRLBF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, CRLBF has a market cap of 236.4M. Regarding current trading prices, TSMRF is priced at $23.74, while CRLBF trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas CRLBF's P/E ratio is -2.92. In terms of profitability, TSMRF's ROE is +0.11%, compared to CRLBF's ROE of -0.18%. Regarding short-term risk, TSMRF is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check CRLBF's competition here
TSMRF vs CPHRF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, CPHRF has a market cap of 235.9M. Regarding current trading prices, TSMRF is priced at $23.74, while CPHRF trades at $9.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas CPHRF's P/E ratio is 25.57. In terms of profitability, TSMRF's ROE is +0.11%, compared to CPHRF's ROE of +0.09%. Regarding short-term risk, TSMRF is less volatile compared to CPHRF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check CPHRF's competition here
TSMRF vs VRNOF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, VRNOF has a market cap of 223.8M. Regarding current trading prices, TSMRF is priced at $23.74, while VRNOF trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas VRNOF's P/E ratio is -0.62. In terms of profitability, TSMRF's ROE is +0.11%, compared to VRNOF's ROE of -0.22%. Regarding short-term risk, TSMRF is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check VRNOF's competition here
TSMRF vs PLNHF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, TSMRF is priced at $23.74, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, TSMRF's ROE is +0.11%, compared to PLNHF's ROE of -0.34%. Regarding short-term risk, TSMRF is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check PLNHF's competition here
TSMRF vs PHCUF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, PHCUF has a market cap of 159.9M. Regarding current trading prices, TSMRF is priced at $23.74, while PHCUF trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas PHCUF's P/E ratio is 600.00. In terms of profitability, TSMRF's ROE is +0.11%, compared to PHCUF's ROE of +0.00%. Regarding short-term risk, TSMRF and PHCUF have similar daily volatility (0.00).Check PHCUF's competition here
TSMRF vs CBWTF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, CBWTF has a market cap of 141.8M. Regarding current trading prices, TSMRF is priced at $23.74, while CBWTF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas CBWTF's P/E ratio is 5.31. In terms of profitability, TSMRF's ROE is +0.11%, compared to CBWTF's ROE of -0.15%. Regarding short-term risk, TSMRF is less volatile compared to CBWTF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check CBWTF's competition here
TSMRF vs COPHF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, TSMRF is priced at $23.74, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas COPHF's P/E ratio is -0.02. In terms of profitability, TSMRF's ROE is +0.11%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, TSMRF is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check COPHF's competition here
TSMRF vs STMH Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, STMH has a market cap of 127.1M. Regarding current trading prices, TSMRF is priced at $23.74, while STMH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas STMH's P/E ratio is N/A. In terms of profitability, TSMRF's ROE is +0.11%, compared to STMH's ROE of -2.75%. Regarding short-term risk, TSMRF and STMH have similar daily volatility (0.00).Check STMH's competition here
TSMRF vs NWPN Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, TSMRF is priced at $23.74, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas NWPN's P/E ratio is -0.04. In terms of profitability, TSMRF's ROE is +0.11%, compared to NWPN's ROE of +0.13%. Regarding short-term risk, TSMRF is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check NWPN's competition here
TSMRF vs LOVFF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, LOVFF has a market cap of 120.1M. Regarding current trading prices, TSMRF is priced at $23.74, while LOVFF trades at $1.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas LOVFF's P/E ratio is 13.14. In terms of profitability, TSMRF's ROE is +0.11%, compared to LOVFF's ROE of +0.15%. Regarding short-term risk, TSMRF is less volatile compared to LOVFF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check LOVFF's competition here
TSMRF vs HLTRF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, HLTRF has a market cap of 112.4M. Regarding current trading prices, TSMRF is priced at $23.74, while HLTRF trades at $3.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas HLTRF's P/E ratio is -6.26. In terms of profitability, TSMRF's ROE is +0.11%, compared to HLTRF's ROE of -0.24%. Regarding short-term risk, TSMRF is less volatile compared to HLTRF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check HLTRF's competition here
TSMRF vs LPCUF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, LPCUF has a market cap of 110.8M. Regarding current trading prices, TSMRF is priced at $23.74, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas LPCUF's P/E ratio is 18.82. In terms of profitability, TSMRF's ROE is +0.11%, compared to LPCUF's ROE of +0.05%. Regarding short-term risk, TSMRF is less volatile compared to LPCUF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check LPCUF's competition here
TSMRF vs CNVCF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, TSMRF is priced at $23.74, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, TSMRF's ROE is +0.11%, compared to CNVCF's ROE of +9.56%. Regarding short-term risk, TSMRF and CNVCF have similar daily volatility (0.00).Check CNVCF's competition here
TSMRF vs JUSHF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, JUSHF has a market cap of 102.3M. Regarding current trading prices, TSMRF is priced at $23.74, while JUSHF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas JUSHF's P/E ratio is -2.08. In terms of profitability, TSMRF's ROE is +0.11%, compared to JUSHF's ROE of +1.06%. Regarding short-term risk, TSMRF is less volatile compared to JUSHF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check JUSHF's competition here
TSMRF vs GRUSF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, GRUSF has a market cap of 99.2M. Regarding current trading prices, TSMRF is priced at $23.74, while GRUSF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas GRUSF's P/E ratio is -13.34. In terms of profitability, TSMRF's ROE is +0.11%, compared to GRUSF's ROE of -0.89%. Regarding short-term risk, TSMRF is less volatile compared to GRUSF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check GRUSF's competition here
TSMRF vs BIOYF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, BIOYF has a market cap of 96.2M. Regarding current trading prices, TSMRF is priced at $23.74, while BIOYF trades at $8.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas BIOYF's P/E ratio is 17.12. In terms of profitability, TSMRF's ROE is +0.11%, compared to BIOYF's ROE of +0.22%. Regarding short-term risk, TSMRF and BIOYF have similar daily volatility (0.00).Check BIOYF's competition here
TSMRF vs AAWH Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, AAWH has a market cap of 87.8M. Regarding current trading prices, TSMRF is priced at $23.74, while AAWH trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas AAWH's P/E ratio is -1.07. In terms of profitability, TSMRF's ROE is +0.11%, compared to AAWH's ROE of -1.05%. Regarding short-term risk, TSMRF is less volatile compared to AAWH. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check AAWH's competition here
TSMRF vs LRDSF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, LRDSF has a market cap of 84.6M. Regarding current trading prices, TSMRF is priced at $23.74, while LRDSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas LRDSF's P/E ratio is -0.01. In terms of profitability, TSMRF's ROE is +0.11%, compared to LRDSF's ROE of +1.61%. Regarding short-term risk, TSMRF and LRDSF have similar daily volatility (0.00).Check LRDSF's competition here
TSMRF vs ABSCF Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, ABSCF has a market cap of 77.4M. Regarding current trading prices, TSMRF is priced at $23.74, while ABSCF trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas ABSCF's P/E ratio is -7.00. In terms of profitability, TSMRF's ROE is +0.11%, compared to ABSCF's ROE of +0.32%. Regarding short-term risk, TSMRF is less volatile compared to ABSCF. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check ABSCF's competition here
TSMRF vs DUTV Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, DUTV has a market cap of 77.4M. Regarding current trading prices, TSMRF is priced at $23.74, while DUTV trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas DUTV's P/E ratio is N/A. In terms of profitability, TSMRF's ROE is +0.11%, compared to DUTV's ROE of +0.02%. Regarding short-term risk, TSMRF is less volatile compared to DUTV. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check DUTV's competition here
TSMRF vs EOFBY Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, EOFBY has a market cap of 73.7M. Regarding current trading prices, TSMRF is priced at $23.74, while EOFBY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, TSMRF's ROE is +0.11%, compared to EOFBY's ROE of N/A. Regarding short-term risk, TSMRF and EOFBY have similar daily volatility (0.00).Check EOFBY's competition here
TSMRF vs PLNH Comparison July 2025
TSMRF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSMRF stands at 1.8B. In comparison, PLNH has a market cap of 72.6M. Regarding current trading prices, TSMRF is priced at $23.74, while PLNH trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSMRF currently has a P/E ratio of 8.19, whereas PLNH's P/E ratio is -1.59. In terms of profitability, TSMRF's ROE is +0.11%, compared to PLNH's ROE of -0.32%. Regarding short-term risk, TSMRF is less volatile compared to PLNH. This indicates potentially lower risk in terms of short-term price fluctuations for TSMRF.Check PLNH's competition here